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Abstract
Cell death is an effective strategy to limit intracellular infections. Canonical inflammasomes,
including NLRP3, NLRC4, and AIM2, recruit and activate caspase-1 in response to a range of
microbial stimuli and endogenous danger signals. Caspase-1 then promotes the secretion of IL-1β
and IL-18 and a rapid form of lytic programmed cell death termed pyroptosis. A second
inflammatory caspase, mouse caspase-11, mediates pyroptotic death through an unknown non-
canonical inflammasome system in response to cytosolic bacteria. In addition, recent work shows
that inflammasomes can also recruit procaspase-8, initiating apoptosis. The induction of multiple
pathways of cell death has probably evolved to counteract microbial evasion of cell death
pathways.
Introduction
Whilst viral infection is necessarily intracellular, many bacteria also find a replicative or
survival niche within cells, evading immune cell attack. In such cases, death of the infected
cell can benefit the host by cutting short the replicative cycle, and releasing the invader for
killing by neutrophils [1] Alternatively, cell death could be co-opted by pathogens to deplete
immune cells, or to release replicated organisms, enhancing pathogen spread. An emerging
mechanism for microbe-induced cell death involves formation of inflammasome complexes.
Inflammasomes are well known as the route to activation of caspase-1, which cleaves the
precursors of the inflammatory cytokines IL-1β and IL-18 [2]. These cytokines are of great
importance in clearance of a number of infections. The induction of cell death by
inflammasomes is less studied, but analysis in fish suggests that the inflammasome system
evolved as part of a cell death program, and that cytokine processing was a later
development [3]. In this review we examine the pathways of inflammasome-induced cell
death, and what is known of the contribution of this process to host defense. The role of non-
inflammasome cell death pathways in bacterial infection has been reviewed elsewhere [4].
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Caspases in apoptosis and pyroptosis
For many years programmed cell death was synonymous with apoptosis. Apoptosis is
described as “immunologically silent”, as cell membrane integrity is normally maintained
until cells are engulfed by phagocytes (Fig. 1). A lack of inflammatory consequence of
apoptosis is important during development and homeostasis. Apoptosis can also be induced
by infection, and in that case, immunologically silent death is undesirable and unlikely,
since the dying cell contains microbial products that should activate the engulfing
macrophage. Cell death by necrosis, involving cell swelling and lysis, was long seen as the
passive response to overwhelming environmental stress or injury, independent of signaling
pathways. However, programmed necrosis (“necroptosis”), involving RIP1/RIP3 signaling
has now been described, and is reviewed elsewhere [5]. Pyroptosis is another form of
programmed lytic cell death, frequently induced by infection. Pyroptotic death elicits
inflammation due to release of cytosolic contents such as ATP, HMGB1 and IL-1α, and is
commonly accompanied by processing of inflammatory cytokines IL-1β and IL-18 (Fig. 1)
[1,2].
Both pyroptosis and apoptosis involve activation of members of the caspase family of
proteases. Pyroptosis is established as inflammasome-dependent cell death, executed
following activation of inflammatory caspases (caspase-1 or mouse caspase-11). In contrast,
apoptotic initiator caspases (caspases-2, -8 and -9) subsequently cleave effector caspases
(caspases-3, -6 and -7). Caspases then cleave target proteins to trigger programmed
pyroptotic or apoptotic cell death. The critical step in commitment to both pathways is the
recruitment of initiator caspases into a protein complex where they are activated by
dimerization, generally followed by intermolecular cleavage. Caspases-1, -2, -8 and -9 are
each recruited into unique activating complexes via their N terminal pro-domain of the
death-fold family (either a caspase recruitment domain (CARD) or death effector domain
(DED)). For example, the caspase-1 and -9 activating platforms are the inflammasome and
apoptosome, respectively [6].
Inflammasome induction of pyroptosis
Inflammasomes activating caspase-1 are initiated either by a Nod-like receptor (NLRP1, 3,
6, 7, 12, NLRC4), AIM2, or Pyrin, all of which contain a CARD or pyrin domain (PYD)
(Fig. 2) [2,7]. While NLRP3 responds to a wide array of agonists [2], NLRC4 is specific for
cytosolic bacterial flagellin and type III secretion system (T3SS) components [8–11], and
AIM2 is specific for cytosolic DNA [12–15]. Many inflammasomes recruit the ASC
adaptor, composed of a CARD and a PYD [2], via homotypic interactions. Additional ASC
molecules are incorporated via CARD-CARD and PYD-PYD interactions, until all ASC is
collected into a single focus (Fig. 2). Attraction of procaspase-1 into the ASC focus via
CARD-CARD interaction results in its dimerization and proximity-induced autoproteolytic
processing into p10 and p20 subunits. This processed and catalytically active caspase-1
cleaves pro-IL-1β and pro-IL-18.
NLRC4 contains a CARD that can recruit procaspase-1 directly, although caspase-1
activation for IL-1β processing also requires ASC. However NLRC4-induced pyroptosis
requires neither the characteristic ASC focus, nor the cleavage of procaspase-1 into p10 and
p20 subunits. In the absence of ASC, a spatially diffuse, unprocessed, but catalytically active
caspase-1 induces pyroptosis but not cytokine processing [16,17]. A diffuse localization for
pyroptotic caspase-1 may facilitate cleavage of the unknown substrates responsible for
pyroptosis. It is not known whether there is a similar paradigm of spatially and
proteolytically distinct caspase-1 downstream of PYD inflammasomes (such as NLRP3 or
AIM2) that only signal through ASC.
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Pyroptosis occurs after activation of either caspase-1 or caspase-11, depending on the
stimulus. The upstream platform(s) that recruits and activates caspase-11 remains to be
defined. The catalytic targets of these caspases which lead to pyroptosis are also unknown,
although the catalytic site of caspase-1 is essential as cells expressing only catalytically
inactive caspase-1 are resistant to pyroptosis [16].
Protective role of caspase-1-dependent pyroptosis in vivo
Many pathogens have evolved strategies to resist the antimicrobial activities of macrophages
and to replicate within them, effectively sequestering the bacteria away from extracellular
immune defenses. Such pathogens have often not evolved mechanisms to evade
extracellular defenses. Pyroptosis attacks this Achilles heel by lysing the infected cell and
exposing pathogens to extracellular defenses, for example transferring them to neutrophils,
which have significantly greater antimicrobial activities. This was first shown using
modified S. typhimurium and L. monocytogenes strains [18–20]. In these cases, while
IL1b−/−IL18−/− mice cleared the infection, Casp1−/−Casp11−/− failed to do so. This suggests,
but does not prove, a role for pyroptosis. Because mice specifically competent for IL-1β and
IL-18 secretion but lacking pyroptosis do not exist, several pieces of ancillary data are
needed to support pyroptosis as the active process (Table 1). There is also evidence that
Francisella novicida, Burkholderia thailandensis, and Burkholderia pseudomallei can be
cleared fully or in part by pyroptosis [21–23] (Table 1). Some of these analyses become
complex; for example during B. pseudomallei infection, IL-18 and pyroptosis are protective,
while IL-1β has detrimental effects [21]. Normally, IL-1β recruits neutrophils that clear
bacteria to the benefit of the host, however, excessive neutrophil influx may result in tissue
damage to the detriment of the host. In many of these infections, the relative roles of
cytokines and pyroptosis may depend on the dose and/or route of infection, and it is likely
that in natural infections IL-1β, IL-18, and pyroptosis will work additively or collectively to
mediate protection.
Non-canonical inflammasome-dependent pyroptosis in defense against
bacteria
Murine caspase-11 induces pyroptosis independent of caspase-1, but also promotes
processing of IL-1β through the NLRP3-ASC-caspase-1 pathway [24]. It remains unclear
whether human caspase-4 or -5 are functionally analogous/equivalent to murine caspase-11.
Kayagaki et al. hypothesized that caspase-11 would be recruited to an oligomerized platform
similar to known caspase-1-activating inflammasomes. To differentiate these two pathways,
Kayagaki defined “canonical inflammasomes” as those that activate caspase-1 and “non-
canonical inflammasomes” as the hypothetical platform(s) for caspase-11 activation [24].
Caspase-11 expression is primed through a TLR4-TRIF-IFN-β-STAT1 pathway [25–29], or
an IFN-γ-STAT1 pathway [22,28,30]. Caspase-11 is activated by prolonged exposure to the
cholera toxin B subunit or many Gram-negative bacteria in vitro [24–27,31]. However,
caspase-11 was not shown to benefit the host during in vivo Citrobacter or Salmonella
infection [25,26]. In contrast, we recently showed that rapid caspase-11 activation in
response to cytosolic bacteria is protective in vivo [22].
Burkholderia pseudomallei is a highly virulent pathogen that causes melioidosis, and is
classified as a potential biologic weapon. B. thailandensis is a closely related species
expressing similar virulence factors, but is avirulent [32]. We showed that Burkholderia
triggers caspase-11 activation within four hours post infection, and that this was dependent
upon their ability to lyse the phagosome and enter the cytosol. The absence of caspase-11
causes mice to be acutely susceptible to both B. pseudomallei and B. thailandensis [22].
Interestingly, while B. thailandensis is avirulent, in the absence of caspase-11 this bacterium
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becomes lethal. Similarly, caspase-11 initiated pyroptosis after aberrant cytosolic release of
naturally vacuolar bacteria. Mutation of a specific T3SS effector, sifA in S. typhimurium
causes rupture of the Salmonella-containing vacuole, and a similar phenotype is described
for L. pneumophila sdhA mutants. This exit from the vacuole results in caspase-11 detection
and played an important role in the clearance of S. typhimurium ΔsifA in vivo [22].
Can the protective roles of caspase-11 against cytosolic bacteria be attributed to pyroptosis,
or do IL-1β and IL-18 play a role? For S. typhimurium ΔsifA infection, IL-1β and IL-18
play no role [22]. The clearance of B. thailandensis was partially dependent upon IL-1β/
IL-18, but only after intranasal infection [22]. We previously showed that the clearance of
bacteria after pyroptosis is mediated by neutrophils through generation of reactive oxygen
[18]. Indeed, NADPH oxidase deficient Ncf1−/− (p47phox) mice were defective for clearance
of S. typhimurium ΔsifA [22]. These results suggest pyroptosis as the mechanism of
clearance of cytosolic bacteria (Table 1).
Inflammasome-dependent cell death in defense against viruses
A wide range of DNA and RNA viruses activate inflammasome pathways (reviewed in
[33]). Inflammasome-dependent cell death in vitro has been observed for both West Nile
virus [34] and adenovirus [35], but the contribution of this to antiviral defense in vivo
remains to be established.
Detrimental effects of pyroptosis in vivo
If too many host cells undergo pyroptosis, detrimental effects may occur due to the release
of inflammatory cytosolic mediators or the depletion of host cells. In vivo caspase-11 can be
activated by triggers other than cytosol-localized bacteria, including LPS, hypoxia, and ER
stress [24,36–38]. LPS-induced septic shock has been shown to require caspase-11 [24,36],
suggesting that overwhelming infection may promote pathological caspase-11 activation.
The role of caspase-11 in septic shock was not explained by IL-1β and IL-18 production,
suggesting a role for pyroptosis [39]. It is still unclear what events downstream of
caspase-11 cause lethality in sepsis, but HMGB1 release has been implicated [40].
Identification of signals activating caspase-11 and the subsequent downstream events will
clarify the dual role of caspase-11 in host protection and immunopathology.
In the setting of unresolved bacterial infections that trigger pyroptosis, such as S.
typhimurium FliCON in an NADPH oxidase-deficient mouse, lysis and depletion of
macrophages in the spleen by pyroptosis causes breakdown of normal splenic architecture
[18]. Similarly, constitutively active Nlrp1a germline mutations cause pyroptosis in the
hematopoietic progenitor cells, resulting in basal myelosuppression [41].
Inflammasome induction of apoptosis
Recent work showed that inflammasomes trigger apoptosis in addition to pyroptosis.
Initially, AIM2 was observed to activate caspase-3 in parallel with caspase-1 [15].
Subsequently, AIM2 recognition of DNA released by the cytosolic bacterium Francisella
novicida [42], the NLRP3 response to the bacterial pore-forming toxin nigericin [43], and
ASC-dependent recognition of Legionella and Salmonella [44,45] have been shown to elicit
apoptotic caspase activation. Although wild type cells rapidly undergo pyroptosis with
inflammasome stimuli, caspase-1 knockout cells were observed to undergo apoptosis, with a
slower timecourse [42,43,45]. Although it was suggested that caspase-1 inhibits the
inflammasome-dependent activation of apoptotic caspases by Salmonella [45], apoptotic
responses can be readily observed in wild type cells responding to AIM2 or NLRP3 stimuli
[43]. We found that the balance between apoptosis and pyroptosis in wild type cells
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depended on the dose of stimulus applied, with apoptosis predominating at low doses [43].
Thus the type of cell death occurring in infections may depend on the magnitude of the
microbial burden.
AIM2 and NLRP3 inflammasome-dependent apoptosis requires caspase-8, which is
recruited to the inflammasome via a novel heterotypic interaction between its DED domains
and the PYD of ASC [42,43,46]. An apoptotic pathway involving ASC and caspase-8 is
consistent with literature from the cancer field, although signaling pathways upstream of
ASC relevant to cancer cells have not been established [47]. ASC was initially identified and
characterized as an apoptosis-associated protein forming dense perinuclear specks in a
leukemia cell line upon treatment with chemotherapeutic drugs [48].
An increased susceptibility of Asc−/− mice to infection in comparison to Casp1−/− mice
would suggest a physiologic function of the ASC-caspase-8 pathway in vivo, and there are
some potential leads in the literature. ASC-dependent apoptosis limited F. novicida
replication in vitro, and in vivo Asc−/− mice defective in their IFN-γ production in
comparison to Casp1−/− mice [42]. Initially, indirect comparisons suggested that Asc−/−
mice were more susceptible to in vivo F. novicida infection than Casp1−/− mice [23].
However upon later direct comparison, they were found to succumb with identical kinetics
[42], indicating that in this case ASC-dependent apoptosis does not confer a survival benefit
in vivo, although different doses or routes of infection should be examined. Asc−/− mice
have also been suggested to be more susceptible than Casp1−/− mice to Mycobacterium
tuberculosis infection [49], although this is disputed [50]. Inflammasome-induced apoptosis
may be particularly important for combating pathogens that directly inhibit caspase-1; the
Yersinia T3SS effector YopM directly inhibits caspase-1 via pseudo-substrate binding to the
catalytic site [51]. Caspase-8 may escape YopM inhibition and could serve as a backup
system for inflammasome signaling.
Conclusion
Initiation of cell death pathways is a fundamental and evolutionarily ancient defense against
infection [52,53]. The presence of pathogen-encoded inhibitors of inflammasome pathways
provides evidence for an important role for the inflammasome in vivo [33,51,54].
Inflammasome-dependent cell death and cytokine production are likely to work together to
promote clearance, but in certain infections, one or the other may have a dominant
individual contribution. Caspase-11-induced pyroptosis, and Inflammasome-induced
apoptosis are newly appreciated, and their roles in a range of infections remain to be tested.
Wherever Asc−/− mice have a more severe defect in host defense than Casp1−/− mice, a role
for ASC-dependent apoptosis should be considered. There is good evidence that pyroptosis
can benefit the host during infection, but it may be detrimental during overwhelming
infection or sepsis. Some pathogens may trigger inflammasome-induced cell death as a
virulence strategy to remove host immune cells or promote pathogen spread..
Acknowledgments
This work is supported by the Australian Research Council Future Fellowship FT0991576 (KJS), National Health
and Medical Research Council grants 631472 (KJS) and 1010887 (KJS), and National Institute of Health grants
AI097518 (EAM) and AI057141 (EAM).
References
1. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;
243:206–214. [PubMed: 21884178]
Aachoui et al. Page 5













2. Moltke Von J, Ayres JS, Kofoed EM, Chavarría-Smith J, Vance RE. Recognition of Bacteria by
Inflammasomes. Annu Rev Immunol. 201210.1146/annurev-immunol-032712-095944
3. Angosto D, López-Castejón G, López-Muñoz A, Sepulcre MP, Arizcun M, Meseguer J, Mulero V.
Evolution of inflammasome functions in vertebrates: Inflammasome and caspase-1 trigger fish
macrophage cell death but are dispensable for the processing of IL-1β. Innate Immunity. 2012;
18:815–824. [PubMed: 22456941]
4. Ashida H, Mimuro H, Ogawa M, Kobayashi T, Sanada T, Kim M, Sasakawa C. Cell death and
infection: a double-edged sword for host and pathogen survival. The Journal of Cell Biology. 2011;
195:931–942. [PubMed: 22123830]
5. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. Many stimuli pull the necrotic trigger, an
overview. Cell Death Differ. 2011; 19:75–86. [PubMed: 22075985]
6. Mace PD, Riedl SJ. Molecular cell death platforms and assemblies. Current Opinion in Cell
Biology. 2010; 22:828–836. [PubMed: 20817427]
7. Chae JJ, Cho Y-H, Lee G-S, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL. Gain-of-
Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe
Autoinflammation in Mice. Immunity. 2011; 34:755–768. [PubMed: 21600797]
8. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A. Cytoplasmic
flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nature Immunology. 2006;
7:569–575. [PubMed: 16648853]
9. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, Leaf IA, Aderem A. From
the Cover: Innate immune detection of the type III secretion apparatus through the NLRC4
inflammasome. Proceedings of the National Academy of Sciences. 2010; 107:3076–3080.
10. Zhao Y, Yang J, Shi J, Gong Y-N, Lu Q, Xu H, Liu L, Shao F. The NLRC4 inflammasome
receptors for bacterial flagellin and type III secretion apparatus. Nature. 2011; 477:596–600.
[PubMed: 21918512]
11. Kofoed EM, Vance RE. Innate immune recognition of bacterial ligands by NAIPs determines
inflammasome specificity. Nature. 2011; 477:592–595. [PubMed: 21874021]
12. Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and
cell death in response to cytoplasmic DNA. Nature. 2009; 458:509–513. [PubMed: 19158676]
13. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E,
Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating
inflammasome with ASC. Nature. 2009; 458:514–518. [PubMed: 19158675]
14. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, Planyavsky M, Bilban M,
Colinge J, Bennett KL, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a
cytoplasmic DNA sensor for the inflammasome. Nature Immunology. 2009; 10:266–272.
[PubMed: 19158679]
15. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet
MJ, Ross IL, et al. HIN-200 proteins regulate caspase activation in response to foreign
cytoplasmic DNA. Science. 2009; 323:1057–1060. [PubMed: 19131592]
16••. Broz P, Moltke Von J, Jones JW, Vance RE, Monack DM. Differential requirement for
Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host
Microbe. 2010; 8:471–483. This study showed that caspase-1-dependent pyroptosis and cytokine
processing can occur in spatially distinct locations. Cytokine processing occurs at the ASC focus,
while pyroptosis is triggered by catalytically active, but diffuse and unprocessed caspase-1.
[PubMed: 21147462]
17. Case CL, Roy CR. Asc Modulates the Function of NLRC4 in Response to Infection of
Macrophages by Legionella pneumophila. mBio. 2011; 2:e00117–11–e00117–11. [PubMed:
21771913]
18••. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem
A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular
bacteria. Nature Immunology. 2010; 11:1136–1142. First demonstration that pyroptosis is a
critical innate immune defense mechanism against intracellular bacteria. [PubMed: 21057511]
Aachoui et al. Page 6













19. Warren SE, Duong H, Mao DP, Armstrong A, Rajan J, Miao EA, Aderem A. Generation of a
Listeria vaccine strain by enhanced caspase-1 activation. Eur J Immunol. 2011; 41:1934–1940.
[PubMed: 21538346]
20. Sauer J-D, Pereyre S, Archer KA, Burke TP, Hanson B, Lauer P, Portnoy DA. Listeria
monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are
poor inducers of protective immunity. Proceedings of the National Academy of Sciences. 2011;
108:12419–12424.
21•. Ceballos-Olvera I, Sahoo M, Miller MA, Barrio LD, Re F. Inflammasome-dependent Pyroptosis
and IL-18 Protect against Burkholderia pseudomallei Lung Infection while IL-1β Is Deleterious.
PLoS Pathog. 2011; 7:e1002452. Demonstration of the complexity of the interplay between
IL-1β, IL-18, and pyroptosis. In the case of B. pseudomallei, IL-1β is detrimental to the host,
while IL-18 and pyroptosis are protective. [PubMed: 22241982]
22••. Aachoui Y, Leaf IA, Hagar JA, Fontana MF, Campos CG, Zak DE, Tan MH, Cotter PA, Vance
RE, Aderem A, et al. Caspase-11 Protects Against Bacteria That Escape the Vacuole. Science.
2013; 339:975–978. First demonstration that caspase-11 detects and protects against cytosolic
bacteria. [PubMed: 23348507]
23. Mariathasan S, Weiss DS, Dixit VM, Monack DM. Innate immunity against Francisella tularensis
is dependent on the ASC/caspase-1 axis. J Exp Med. 2005; 202:1043–1049. [PubMed: 16230474]
24••. Kayagaki N, Warming S, Lamkanfi M, Walle LV, Louie S, Dong J, Newton K, Qu Y, Liu J,
Heldens S, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;
479:117–121. This paper redirected the inflammasome field, revealing that caspase-1 deficient
mice also lacked caspase-11, and revealed a distinct role of caspase-11 in pyroptosis and
cytokine secretion. [PubMed: 22002608]
25. Gurung P, Malireddi RKS, Anand PK, Demon D, Walle LV, Liu Z, Vogel P, Lamkanfi M,
Kanneganti T-D. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing
interferon-β (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4
(TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens. Journal
of Biological Chemistry. 2012; 287:34474–34483. [PubMed: 22898816]
26. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM, Monack DM. Caspase-11
increases susceptibility to Salmonella infection in the absence of caspase-1. Nature. 2012;
490:288–291. [PubMed: 22895188]
27. Rathinam VAK, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM,
Fitzgerald KA. TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by
Gram-Negative Bacteria. Cell. 2012; 150:606–619. [PubMed: 22819539]
28. Schauvliege R, Vanrobaeys J, Schotte P, Beyaert R. Caspase-11 gene expression in response to
lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer
and activator of transcription (STAT) 1. J Biol Chem. 2002; 277:41624–41630. [PubMed:
12198138]
29. Case CL, Kohler LJ, Lima JB, Strowig T, de Zoete MR, Flavell RA, Zamboni DS, Roy CR.
Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella
pneumophila. Proceedings of the National Academy of Sciences. 2013; 110:1851–1856.
30. Hur J, Kim SY, Kim H, Cha S, Lee MS, Suk K. Induction of caspase-11 by inflammatory stimuli
in rat astrocytes: lipopolysaccharide induction through p38 mitogen-activated protein kinase
pathway. FEBS Lett. 2001; 507:157–162. [PubMed: 11684090]
31. Akhter A, Caution K, Abu Khweek A, Tazi M, Abdulrahman BA, Abdelaziz DHA, Voss OH,
Doseff AI, Hassan H, Azad AK, et al. Caspase-11 promotes the fusion of phagosomes harboring
pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity. 2012; 37:35–
47. [PubMed: 22658523]
32. Wiersinga WJ, Van Der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the
pathogenicity of Burkholderia pseudomallei. Nat Rev Micro. 2006; 4:272–282.
33. Gram AM, Frenkel J, Ressing ME. Inflammasomes and viruses: cellular defence versus viral
offence. Journal of General Virology. 2012; 93:2063–2075. [PubMed: 22739062]
34. Wu M-F, Chen S-T, Yang A-H, Lin W-W, Lin Y-L, Chen N-J, Tsai I-S, Li L, Hsieh S-L. CLEC5A
is critical for dengue virus-induced inflammasome activation in human macrophages. Blood. 2013;
121:95–106. [PubMed: 23152543]
Aachoui et al. Page 7













35. Barlan AU, Griffin TM, McGuire KA, Wiethoff CM. Adenovirus membrane penetration activates
the NLRP3 inflammasome. Journal of Virology. 2011; 85:146–155. [PubMed: 20980503]
36. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease,
is essential for the activation of ICE. Cell. 1998; 92:501–509. [PubMed: 9491891]
37. Kim N-G, Lee H, Son E, Kwon O-Y, Park J-Y, Park J-H, Cho GJ, Choi WS, Suk K. Hypoxic
induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Res Mol Brain Res.
2003; 114:107–114. [PubMed: 12829320]
38. Endo M, Mori M, Akira S, Gotoh T. C/EBP homologous protein (CHOP) is crucial for the
induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation. J
Immunol. 2006; 176:6245–6253. [PubMed: 16670335]
39. Sarkar A, Hall MW, Exline M, Hart J, Knatz N, Gatson NT, Wewers MD. Caspase-1 regulates
Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and
interleukin-18. American Journal of Respiratory and Critical Care Medicine. 2006; 174:1003–
1010. [PubMed: 16908867]
40•. Lamkanfi M, Sarkar A, Vande Walle L, Vitari AC, Amer AO, Wewers MD, Tracey KJ,
Kanneganti T-D, Dixit VM. Inflammasome-dependent release of the alarmin HMGB1 in
endotoxemia. The Journal of Immunology. 2010; 185:4385–4392. Antibodies against HMGB1
protected mice from LPS challenge. Together with the data from Kayagaki et al. [28] this paper
suggests that release of cytosolic danger molecules by pyroptosis causes mortality during septic
shock. [PubMed: 20802146]
41. Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O’Donnell JA, McArthur K, Baldwin
TM, Chevrier S, Nowell CJ, et al. NLRP1 Inflammasome Activation Induces Pyroptosis of
Hematopoietic Progenitor Cells. Immunity. 2012; 37:1009–1023. [PubMed: 23219391]
42••. Pierini R, Juruj C, Perret M, Jones CL, Mangeot P, Weiss DS, Henry T. AIM2/ASC triggers
caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell
Death Differ. 2012; 19:1709–1721. Demonstrated that activation of the AIM2-ASC
inflammasome can lead to apoptosis in addition to pyroptosis. [PubMed: 22555457]
43••. Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vijjhala PR, Roberts TL, Schroder
K, Vince JE, Hill JM, et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and
pyroptotic death pathways via ASC. Cell Death Differ. 2013 in press Showed caspase-8
dependent apoptosis in response to AIM2 and NLRP3 stimuli, recruitment of procaspase-8 to the
ASC focus, and stimulus dose dependent switch between inflammasome-induced apoptosis and
pyroptosis.
44. Abdelaziz DHA, Gavrilin MA, Akhter A, Caution K, Kotrange S, Khweek AA, Abdulrahman BA,
Hassan ZA, El-Sharkawi FZ, Bedi SS, et al. Asc-Dependent and Independent Mechanisms
Contribute to Restriction of Legionella Pneumophila Infection in Murine Macrophages. Front
Microbiol. 2011:2. [PubMed: 21687401]
45. Puri AW, Broz P, Shen A, Monack DM, Bogyo M. Caspase-1 activity is required to bypass
macrophage apoptosis upon Salmonella infection. Nat Chem Biol. 2012; 8:745–747. [PubMed:
22797665]
46. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M, Zhu L, Katsuyama T, Sagara J,
Taniguchi S, et al. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent
apoptosis. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2003;
303:69–73. [PubMed: 12646168]
47. Motani K, Kawase K, Imamura R, Kinoshita T, Kushiyama H, Suda T. Activation of ASC induces
apoptosis or necrosis, depending on the cell type, and causes tumor eradication. Cancer Sci. 2010;
101:1822–1827. [PubMed: 20500518]
48. Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, Niikawa N, Hidaka E,
Katsuyama T, Higuchi T, Sagara J. ASC, a novel 22-kDa protein, aggregates during apoptosis of
human promyelocytic leukemia HL-60 cells. J Biol Chem. 1999; 274:33835–33838. [PubMed:
10567338]
49. McElvania Tekippe E, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, Sandor M, Braunstein
M, Ting JP-Y. Granuloma formation and host defense in chronic Mycobacterium tuberculosis
infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS ONE. 2010:5.
Aachoui et al. Page 8













50. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny
S, Caspar P, Núñez G, et al. Cutting Edge: Caspase-1 Independent IL-1{beta} Production Is
Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling
In Vivo. J Immunol. 201010.4049/jimmunol.0904189
51. LaRock CN, Cookson BT. The Yersinia Virulence Effector YopM Binds Caspase-1 to Arrest
Inflammasome Assembly and Processing. Cell Host Microbe. 2012; 12:799–805. [PubMed:
23245324]
52. Galluzzi L, Kepp O, Morselli E, Vitale I, Senovilla L, Pinti M, Zitvogel L, Kroemer G. Viral
strategies for the evasion of immunogenic cell death. J Intern Med. 2010; 267:526–542. [PubMed:
20433579]
53. Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell
Host Microbe. 2010; 8:44–54. [PubMed: 20638641]
54. Lamkanfi M, Dixit VM. Modulation of inflammasome pathways by bacterial and viral pathogens.
The Journal of Immunology. 2011; 187:597–602. [PubMed: 21734079]
55. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev
Micro. 2009; 7:99–109.
56. Raupach B, Peuschel S-K, Monack DM, Zychlinsky A. Caspase-1-Mediated Activation of
Interleukin-1 (IL-1 ) and IL-18 Contributes to Innate Immune Defenses against Salmonella
enterica Serovar Typhimurium Infection. Infect Immun. 2006; 74:4922–4926. [PubMed:
16861683]
57. Tsuji NM, Tsutsui H, Seki E, Kuida K, Okamura H, Nakanishi K, Flavell RA. Roles of caspase-1
in Listeria infection in mice. International Immunology. 2004; 16:335–343. [PubMed: 14734619]
Aachoui et al. Page 9














• Pyroptosis is a form of programmed cell death that is lytic and pro-
inflammatory.
• Pyroptosis occurs after caspase-1 or caspase-11 activation.
• ASC can trigger pyroptosis via caspase-1 and apoptosis via caspase-8
• Pyroptosis protects against vacuolar or cytosolic microbes.
• Caspase-11 protects against infection by cytosolic bacteria.
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Figure 1. The cellular events during pyroptosis and apoptosis
Both pyroptosis and apoptosis require activation of caspases, caspase-1/11 or
caspase-2/3/7/8/9, respectively, but differ morphologically. Pyroptosis is characterized by
formation of membrane pores between 1.1 and 2.4 nm in diameter. These pores likely cause
dissipation of cellular ionic gradients leading to osmotic water influx, cell swelling, and
plasma membrane lysis, releasing the cytosolic content into the extracellular space. Specific
markers for this lysis are useful in vitro, for example lactate dehydrogenase release is readily
detected by enzyme assay. Other cytosolic components released have inflammatory biologic
functions, for example HMGB1, IL-1α, and ATP. On the other hand during apoptosis,
plasma membrane integrity is maintained and cellular contents are not released. The plasma
membrane loses leaflet lipid composition asymmetry as phosphatidyl serine becomes
exposed on the outer leaflet, promoting phagocytosis. However, in the absence of
phagocytosis, at later timepoints the apoptotic bodies undergo secondary necrosis
characterized by rupture of the membrane. Apoptosis is an energy requiring process during
which cells shrink and form apoptotic blebs. The DNA repair factor PARP1 is inactivated by
cleavage, and nuclear condensation and fragmentation occur. Internucleosomal DNA
cleavage, detected as laddering on gel electrophoresis or by TUNEL staining for DNA ends,
occurs due to ICAD degradation and activation of CAD (caspase-activated DNase). Weak
TUNEL staining is also seen in pyroptosis, but DNA laddering and ICAD degradation are
absent [55].
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Figure 2. Canonical and non-canonical inflammasome pathways to cell death and cytokine
secretion
Canonical inflammasomes are cytosolic platforms that activate caspase-1 in response to
pathogen- or danger- associated molecular patterns. Activation of caspase-1 leads to
secretion of IL-1β and IL-18, and pyroptosis. Two domain structures for inflammasome
initiator proteins are known. 1) NLRs contain a signaling domain (PYD or CARD), a
nucleotide binding oligomerization domain (NOD/NACHT), and a leucine rich repeat
(LRR) domain. 2) AIM2 contains a PYD signaling domain and a DNA-binding HIN-200
domain. AIM2 detects cytosolic DNA. NLRP3 detects multiple agonists such as
extracellular ATP, bacterial pore-forming toxins, monosodium urate crystals, and
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cholesterol crystals. NLRC4 detects cytosolic flagellin or T3SS components that have been
injected into the cytosol. The NLR or AIM2 signaling domains (PYD or CARD) bind to
ASC by homotypic interactions, triggering formation of the ASC focus, which recruits
procaspase-1, leading to its activation and processing. The ASC focus also recruits
procaspase-8, initiating an apoptotic pathway. NLRC4 can additionally interact directly with
caspase-1, resulting only in pyroptosis. The platform(s) that activate caspase-11 in response
to cytosolic bacteria remain unknown. Caspase-11 triggers pyroptosis directly, and can also
activate the canonical NLRP3-ASC-caspase-1 inflammasome pathway leading to IL-1β and
IL-18 processing (denoted by the long curved arrow to NLRP3).
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